Duration: May 19 - 24, 2023 Venue: Walter E. Washington Convention Center Location: United States Website: Visit the Official Webite Industry Focus: Manufacturing & Processing Machinery Introduction: ATS International Conference will offer the latest information on clinical, basic, and translat...
ATS Conference 2025 In progress American Thoracic Society International Conference Dates: Friday, May 16, 2025 - Wednesday, May 21, 2025 Venue: Moscone Center, San Francisco CA, United StatesATS International Conference will offer the latest information on clinical, basic, and translational science...
Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference /Pieris Pharmaceuticals, Inc. (Nasdaq:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for ...
Reference: American Thoracic Society [ATS 2023 International Conference]. (n.d.) Mortality Risk Reduction With Budesonide/Glycopyrrolate/Formoterol Fumarate Versus Fluticasone Furoate/Umeclidinium/Vilanterol in COPD: A Matching-Adjusted Indirect Comparison o...
American Thoracic Society [ATS 2023 International Conference]. (n.d.) Small Airways Deposition of Two Fixed-dose Triple Therapy Combinations Assessed With Functional Respiratory Imaging (FRI) Retrieved 16thMay,2023 [overdue date: May 21st2025], from ...
This is a summary of the Pediatric Pulmonary Medicine Core Curriculum presented at the 2023 American Thoracic Society International Conference. The respiratory disorders of infancy discussed in this year's review include: the care of the patient with bronchopulmonary dysplasia in the neonatal inte...
American Thoracic Society [ATS 2023 International Conference]. (n.d.) Budesonide/Glycopyrrolate/Formoterol Fumarate Effects on Exacerbations of Chronic Obstructive Pulmonary Disease Based on Airflow Limitation: A Post-hoc Analysis of the KRONO...
American Thoracic Society [ATS 2023 International Conference]. (n.d.) Small Airways Deposition of Two Fixed-dose Triple Therapy Combinations Assessed With Functional Respiratory Imaging (FRI) Retrieved 16thMay,2023 [overdue date: May 21st2025], from ...
American Thoracic Society [ATS 2023 International Conference]. (n.d.) Exacerbations and Real-world Outcomes (EROS) Among Patients With COPD Receiving Single Inhaler Triple Therapy of Budesonide/glycopyrrolate/formoterol Fumarate Retrieved 16th May,2023 [overdue date: May 23rd 2025], from https://www...
American Thoracic Society [ATS 2023 International Conference]. (n.d.) Budesonide/Glycopyrrolate/Formoterol Fumarate Effects on Exacerbations of Chronic Obstructive Pulmonary Disease Based on Airflow Limitation: A Post-hoc Analysis of the KRONOS Study Retrieved 17th May,2023 [overdue date: May 22nd 2025...